Ozekibart Triplet Shows Superior Response Rates in Ewing SarcomaByRashmi Chugh, MDApril 23rd 2026Rashmi Chugh, MD, discusses the early outcomes of a trial of ozekibart plus chemotherapy in Ewing sarcoma.
Rationale for Ozekibart Plus Chemotherapy for Relapsed Ewing SarcomaByRashmi Chugh, MDApril 22nd 2026Rashmi Chugh, MD, describes the background for a study of ozekibart in Ewing sarcoma.